Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 105 (6), 1123-1129
- https://doi.org/10.1067/mai.2000.106043
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthmaClinical Therapeutics, 1999
- Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstructionJournal of Allergy and Clinical Immunology, 1998
- Should Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?American Journal of Respiratory and Critical Care Medicine, 1998
- Should Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?American Journal of Respiratory and Critical Care Medicine, 1998
- Inhaled Corticosteroids and the Prevention of Readmission to Hospital for AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Efficacy and Safety of Inhaled CorticosteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997
- A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of AsthmaJournal of Asthma, 1996
- Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.American Journal of Respiratory and Critical Care Medicine, 1994
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987